Stancic Ana
Insider CIK 1320271 · IMNP Director · KVA Director · ENZN Executive VP, COO, PEO, CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMNP IMMUNE PHARMACEUTICALS INC | A Award deriv | 2015-01-08 | 2015-01-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy deriv | 2014-11-26 | 2014-12-03 | 2,000 | — | $0 | 2,000 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy | 2014-11-26 | 2014-12-03 | 8,000 | $2.50 | $20.0K | 8,000 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | A Award deriv | 2013-10-10 | 2013-10-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | A Award deriv | 2013-10-10 | 2013-10-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KVA/KVB K-V Pharmaceutical Co | J Other deriv | 2013-09-16 | 2013-09-27 | 10,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB K-V Pharmaceutical Co | J Other deriv | 2013-09-16 | 2013-09-27 | 7,500 | — | $0 | 0 | SEC↗ |
| KVA/KVB K-V Pharmaceutical Co | J Other deriv | 2013-09-16 | 2013-09-27 | 20,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB K-V Pharmaceutical Co | J Other deriv | 2013-09-16 | 2013-09-27 | 20,000 | — | $0 | 0 | SEC↗ |
| KVA KV PHARMACEUTICAL CO /DE/ | A Award deriv | 2012-05-14 | 2012-05-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award | 2012-01-17 | 2012-01-19 | 45,000 | — | $0 | 70,000 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | D To issuer | 2012-01-17 | 2012-01-19 | 45,000 | — | $0 | 15,000 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award deriv | 2011-11-17 | 2012-01-19 | 125,000 | — | $0 | 125,000 | SEC↗ |